FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016544327> ?p ?o ?g. }

• W2016544327 endingPage "4860" @default.
• W2016544327 startingPage "4853" @default.
• W2016544327 abstract "As part of a larger search for potent as well as selective inhibitors of dihydrofolate reductase (DHFR) enzymes from opportunistic pathogens found in patients with AIDS and other immune disorders, N-[(2,4-diaminopteridin-6-yl)methyl]dibenz[b,f]azepine (4a) and the corresponding dihydrodibenz[b,f]azepine, dihydroacridine, phenoxazine, phenothiazine, carbazole, and diphenylamine analogues were synthesized from 2, 4-diamino-6-(bromomethyl)pteridine in 50-75% yield by reaction with the sodium salts of the amines in dry tetrahydrofuran at room temperature. The products were tested for the ability to inhibit DHFR from Pneumocystis carinii (pcDHFR), Toxoplasma gondii (tgDHFR), Mycobacterium avium (maDHFR), and rat liver (rlDHFR). The member of the series with the best combination of potency and species selectivity was 4a, with IC(50) values against the four enzymes of 0. 21, 0.043, 0.012, and 4.4 microM, respectively. The dihydroacridine, phenothiazine, and carbazole analogues were also potent, but nonselective. Of the compounds tested, 4a was the only one to successfully combine the potency of trimetrexate with the selectivity of trimethoprim. Molecular docking simulations using published 3D structural coordinates for the crystalline ternary complexes of pcDHFR and hDHFR suggested a possible structural interpretation for the binding selectivity of 4a and the lack of selectivity of the other compounds. According to this model, 4a is selective because of a unique propensity of the seven-membered ring in the dibenz[b,f]azepine moiety to adopt a puckered orientation that allows it to fit more comfortably into the active site of the P. carinii enzyme than into the active site of the human enzyme. Compound 4a was also evaluated for the ability to be taken up into, and retard the growth of, P. carinii and T. gondii in culture. The IC(50) of 4a against P. carinii trophozoites after 7 days of continuous drug treatment was 1.9 microM as compared with previously observed IC(50) values of >340 microM for trimethoprim and 0.27 microM for trimetrexate. In an assay involving [(3)H]uracil incorporation into the nuclear DNA of T. gondii tachyzoites as the surrogate endpoint for growth, the IC(50) of 4a after 5 h of drug exposure was 0.077 microM. The favorable combination of potency and enzyme selectivity shown by 4a suggests that this novel structure may be an interesting lead for structure-activity optimization." @default.
• W2016544327 created "2016-06-24" @default.
• W2016544327 creator A5004578215 @default.
• W2016544327 creator A5004746201 @default.
• W2016544327 creator A5055670356 @default.
• W2016544327 creator A5071627490 @default.
• W2016544327 creator A5088782676 @default.
• W2016544327 creator A5091180366 @default.
• W2016544327 date "1999-10-22" @default.
• W2016544327 modified "2023-09-23" @default.
• W2016544327 title "Structure-Based Design of Selective Inhibitors of Dihydrofolate Reductase: Synthesis and Antiparasitic Activity of 2,4-Diaminopteridine Analogues with a Bridged Diarylamine Side Chain" @default.
• W2016544327 cites W1994159235 @default.
• W2016544327 cites W1994946938 @default.
• W2016544327 cites W2022331577 @default.
• W2016544327 cites W2038547300 @default.
• W2016544327 cites W2039785166 @default.
• W2016544327 cites W2043234874 @default.
• W2016544327 cites W2051124537 @default.
• W2016544327 cites W2055025009 @default.
• W2016544327 cites W2059614919 @default.
• W2016544327 cites W2060463809 @default.
• W2016544327 cites W2066253358 @default.
• W2016544327 cites W2067444617 @default.
• W2016544327 cites W2075578161 @default.
• W2016544327 cites W2089323758 @default.
• W2016544327 cites W2091632754 @default.
• W2016544327 cites W2146642815 @default.
• W2016544327 cites W2323137666 @default.
• W2016544327 cites W2340061261 @default.
• W2016544327 cites W2342351290 @default.
• W2016544327 cites W2419534685 @default.
• W2016544327 cites W2952497157 @default.
• W2016544327 cites W2953329328 @default.
• W2016544327 cites W1585229160 @default.
• W2016544327 doi "https://doi.org/10.1021/jm990331q" @default.
• W2016544327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10579848" @default.
• W2016544327 hasPublicationYear "1999" @default.
• W2016544327 type Work @default.
• W2016544327 sameAs 2016544327 @default.
• W2016544327 citedByCount "41" @default.
• W2016544327 countsByYear W20165443272012 @default.
• W2016544327 countsByYear W20165443272014 @default.
• W2016544327 countsByYear W20165443272015 @default.
• W2016544327 countsByYear W20165443272016 @default.
• W2016544327 countsByYear W20165443272017 @default.
• W2016544327 countsByYear W20165443272019 @default.
• W2016544327 countsByYear W20165443272022 @default.
• W2016544327 countsByYear W20165443272023 @default.
• W2016544327 crossrefType "journal-article" @default.
• W2016544327 hasAuthorship W2016544327A5004578215 @default.
• W2016544327 hasAuthorship W2016544327A5004746201 @default.
• W2016544327 hasAuthorship W2016544327A5055670356 @default.
• W2016544327 hasAuthorship W2016544327A5071627490 @default.
• W2016544327 hasAuthorship W2016544327A5088782676 @default.
• W2016544327 hasAuthorship W2016544327A5091180366 @default.
• W2016544327 hasConcept C114373084 @default.
• W2016544327 hasConcept C142724271 @default.
• W2016544327 hasConcept C159047783 @default.
• W2016544327 hasConcept C178790620 @default.
• W2016544327 hasConcept C181199279 @default.
• W2016544327 hasConcept C185592680 @default.
• W2016544327 hasConcept C202751555 @default.
• W2016544327 hasConcept C2776127813 @default.
• W2016544327 hasConcept C2776275976 @default.
• W2016544327 hasConcept C2777040443 @default.
• W2016544327 hasConcept C2777559004 @default.
• W2016544327 hasConcept C2778622868 @default.
• W2016544327 hasConcept C2778716775 @default.
• W2016544327 hasConcept C2781320022 @default.
• W2016544327 hasConcept C2781421772 @default.
• W2016544327 hasConcept C2993443204 @default.
• W2016544327 hasConcept C3013748606 @default.
• W2016544327 hasConcept C55493867 @default.
• W2016544327 hasConcept C71240020 @default.
• W2016544327 hasConcept C71924100 @default.
• W2016544327 hasConcept C86803240 @default.
• W2016544327 hasConcept C98274493 @default.
• W2016544327 hasConceptScore W2016544327C114373084 @default.
• W2016544327 hasConceptScore W2016544327C142724271 @default.
• W2016544327 hasConceptScore W2016544327C159047783 @default.
• W2016544327 hasConceptScore W2016544327C178790620 @default.
• W2016544327 hasConceptScore W2016544327C181199279 @default.
• W2016544327 hasConceptScore W2016544327C185592680 @default.
• W2016544327 hasConceptScore W2016544327C202751555 @default.
• W2016544327 hasConceptScore W2016544327C2776127813 @default.
• W2016544327 hasConceptScore W2016544327C2776275976 @default.
• W2016544327 hasConceptScore W2016544327C2777040443 @default.
• W2016544327 hasConceptScore W2016544327C2777559004 @default.
• W2016544327 hasConceptScore W2016544327C2778622868 @default.
• W2016544327 hasConceptScore W2016544327C2778716775 @default.
• W2016544327 hasConceptScore W2016544327C2781320022 @default.
• W2016544327 hasConceptScore W2016544327C2781421772 @default.
• W2016544327 hasConceptScore W2016544327C2993443204 @default.
• W2016544327 hasConceptScore W2016544327C3013748606 @default.
• W2016544327 hasConceptScore W2016544327C55493867 @default.
• W2016544327 hasConceptScore W2016544327C71240020 @default.
• W2016544327 hasConceptScore W2016544327C71924100 @default.
• W2016544327 hasConceptScore W2016544327C86803240 @default.

• next